Hepatitis G virus (HGV) infection is more common than hepatitis C virus (HCV) infection and is frequently found in healthy individuals. Although parenteral spread of HGV is well recognized, other routes of transmission probably occur as well. In a prospective study of mother-to-infant transmission of hepatitis viruses, 69 pregnant women with antibodies to HCV and their 81 newborn children were included. Serum levels of HCV RNA and HGV RNA were detected by polymerase chain reaction (PCR) assays, and antibodies to HCV and HGV envelope protein E2 were detected by enzyme-linked immunosorbent assay. Fifty-nine of the mothers had HCV viremia, whereas 16 had HGV viremia. HCV transmission from viremic mothers occurred in 2.8% -4.2% of the cases, whereas HGV transmission from viremic mothers occurred in 75.0% -80.0% of the cases (P õ .001). Sequencing of the PCR products of HGV from the mother-infant serum pairs showed minor differences in most cases but sequence homology in each pair. Although the rate of perinatal HGV transmission highly exceeded that of perinatal HCV transmission, HGV did not seem to induce hepatitis in the children.
Hepatitis G virus (HGV) and GB virus type C, two strain
In this study of mothers with antibody to HCV but not to HIV and their newborn children, we analyzed the prevalences variants of the same virus, have recently been found in serum samples from patients with hepatitis [1, 2] . (For simplification, of HGV viremia and HCV viremia among mothers and their newborns and tested the mothers for antibody to HGV. For the we will use the term HGV in this article.) Despite the history of discovery of HGV, the significance of this virus in liver viremic children and their mothers, partial sequencing of the HGV genome was done. The risk for transmission of the two disease is still controversial. HGV has been associated with acute and chronic hepatitis of unknown origin, but HGV infecviruses was estimated and compared. tion is also often found in individuals lacking signs of liver disease [1 -6] . The prevalence of HGV viremia among blood
Patients and Methods donors (1.5% -2%) exceeds that of hepatitis C virus (HCV) viremia [2, 4, 7 -10] , and HGV viremia is also frequently found
The women in this study were all positive for antibody to in patients infected with HCV [8, 9] . Although parenteral risk HCV by standard screening and immunoblot confirmation factors are common in HGV-infected individuals, many have assays; they were included in an ongoing (since 1982) prospecno apparent risk behavior, and the mode of virus acquisition tive clinical investigation on the perinatal transmission of hepain these subjects remains obscure. However, mother-to-infant titis virus agents in the Göteborg region of Sweden. Before transmission of HCV does occur, generally in õ5% -10% of 1991, only women with histologically confirmed chronic noncases [11 -14] if the mother is not coinfected with HIV. As A, non-B hepatitis who were routinely followed up at our for HGV, recent reports indicate that perinatal transmission department were recruited for the study. Since 1991, the ongooccurs as well [15 -18] .
ing investigation included all pregnant women with known positivity for antibody to HCV who were previously followed up at our department or referred to us after antenatal screening for antibody to HCV, regardless of whether chronic hepatitis Received 21 May 1998 ; revised 30 October 1998.
was histologically confirmed.
The prospective program for the study of perinatal transmission of hepatitis virus infection and the retrospective analysis of hepatitis G virus transmission
In this study, the findings for a total of 69 women and were both approved by the Local Ethics Committee of Göteborg University, their 81 newborn children are reported. These women represent and informed consent for hepatitis G virus testing was obtained from the Ç85% of those included in the ongoing investigation; the other women participating in the study.
Financial support: This study was supported by the Swedish Medical Re-15% were excluded from this study, since no blood samples search Foundation (068-02865-28A), the Alfred Ö sterlund Foundation, and the were obtained from the children. None of the women were medical faculties of Göteborg and Lund Universities.
positive for antibody to HIV or hepatitis B surface antigen. Statistical analysis. The risk (i.e., the probability) of perinatal transmission, including 95% confidence intervals, was delivery; these samples were analyzed for HCV viremia and HGV viremia by using PCR assays and for antibodies to HGV calculated exactly with use of the binomial distribution. Fisher's exact test (double-sided) was used to compare proportions. envelope protein E2. In five pregnancies, only serum samples obtained before and ú1 month after gestation were available, but since analyses of the paired serum samples gave identical Results results, these pregnancies were also included.
Children. After birth, the intention was to follow up the Clinical and virological findings for the women. Fifty-four (78.3%) of the 69 women had biochemical evidence of chronic children until the age of 18-24 months by means of obtaining blood samples at regular intervals for determination of antibody hepatitis (i.e., elevated [above the upper limit of normal] ALT levels on at least two occasions ú6 months apart, before or to HCV (after 1990) and alanine aminotransferase (ALT) levels and for long-term storage of serum samples (020ЊC). Samples after pregnancy). Thirty-two of these women underwent liver biopsy (not during pregnancy); this procedure showed chronic were not obtained from all children at regular intervals. For this study, we selected one sample from each child at around the hepatitis in 30 women, while two had normal liver histology. Repeated testing for 15 women (21.7%) revealed normal ALT age of 1 year (median, 12 months; range, 1-67 months). If this sample was positive for HCV RNA or HGV RNA or if the levels; none of them underwent liver biopsy.
In table 1 the women are divided into four groups according mother was HGV RNA-positive, at least one additional earlier sample (if available) was analyzed for confirmation and to deterto the findings of PCR analysis. Fifty-nine women (85.5%) had HCV viremia. None of the 10 HCV RNA -negative mothers mine the onset of viremia. Antibody to HCV in the children was analyzed at all times when samples were obtained. Further (including one woman with HGV viremia) had elevated ALT levels before or after delivery, and none of them underwent testing for seroconversion to HGV envelope protein E2 was done on the last sample from children who never developed liver biopsy. At least one additional serum sample from six of these 10 women was analyzed for HCV RNA with the same HGV viremia despite having a mother with HGV viremia.
PCR analysis for HCV RNA and HGV RNA. Viral RNA negative result. Thus, these 10 women probably had had a selflimited HCV infection and were not chronically infected with was extracted from serum as previously described [19] with use of water controls between every sample. HCV RNA was HCV. Sixteen mothers (23.2%) had HGV viremia, and 27 (39.1%) had antibody to HGV envelope protein E2. None of detected by using a nested in-house PCR assay as previously described [19] . The sensitivity of this assay for RNA quantithese women had both markers of HGV infection. There was no significant difference in the frequency of tated by branched DNA is around 100 copies/mL. PCR analysis for HGV RNA was performed in a similar way with use of chronic hepatitis (defined as an ALT level above the upper limit of normal on at least two occasions) among women with primers against the 5-noncoding region of HGV as previously described in detail [10] .
isolated HCV infection and those who were coinfected with HCV and HGV (90.9% vs. 93.3%, respectively; P ú .30). Primers in the first round of the PCR assay for HGV RNA were 5-CGGCCAAAAGGTGGTGGATG (sense strand) and 5-Those women with markers of HGV exposure (HGV RNA or antibody to HGV envelope protein E2) seemed more likely CACTGGTCCTTGTCAACTCG (antisense strand), and in the second round they were 5-GGTGATGACAGGGTTGGTAG to be intravenous drug users; however, the difference in the proportion of intravenous drug users was not significant (33 (sense strand) and GCCTATTGGTCAAGAGAGACAT (antisense strand). Sequencing of PCR-amplified products of HGV. HGV PCR the 10 children born to HCV RNA -negative women. HCV viremia was detected in three (4.2%) of the 71 children born fragments were cut out from gels, and the DNA was purified and subjected to cycle sequencing with the inner amplification to mothers with HCV viremia. One child (L1) developed chronic HCV infection that was verified by biopsy at 21 months primers by means of the ABI PRISM TM dye terminator cycle sequencing kit with AmpliTaq DNA polymerase FS (Perkinof age; this child was the only one who actively produced antibody to HCV (figure 1). Cord blood from one child was Elmer, Foster City, CA). Products were then analyzed on an ABI 373 Sequenator (Perkin-Elmer), edited, and aligned by HCV RNA -positive only, but samples from this child that were obtained during further follow-up were repeatedly HCV using the Factura and Sequence Navigator programs (version 1.0.1; Perkin-Elmer).
RNA -negative; ALT levels were consistently normal, and seroconversion to HCV did not occur. (9) 3 (33.3) 8 (88.9) 0 1 (11.1) 0 0 NOTE. HCV Å hepatitis C virus; HGV Å hepatitis G virus; IVDU Å intravenous drug user. * Defined as elevated (above the upper limit of normal) alanine aminotransferase levels before and/or after pregnancy.
obtained was likely. The first available sample from a third one probably had temporary viremia that spontaneously resolved. Of the 71 children born to HCV RNA-positive women, child at 6 months of age was HCV RNA -positive, but samples obtained thereafter were repeatedly negative. As in the previous 67 were followed up for ú12 months, and all of these children lost antibody to HCV with the exception of the child who develchild, ALT levels were normal, and antibody to HCV disappeared.
oped chronic hepatitis C. The remaining four children were followed up for õ12 months, and the last serum samples from Thus, of the three children, one was probably falsely positive because of contamination of cord blood by maternal blood, and these children were still positive for antibody to HCV. The estimated risk for HCV transmission from viremic moththe same child (L1) who became chronically infected with HCV; thus, she developed a chronic coinfection with HCV and ers was 4.2% (three of 71; 95% CI, 0.9% -11.9%) or 2.8% (95% CI, 0.3% -9.8%) if the child with only positive cord HGV ( figure 1) . The other two children with HCV viremia both had HGV RNA -negative mothers and did not become blood was not included because of contamination by maternal blood.
infected with HGV. The woman with isolated HGV viremia transmitted the infection to her child. Thus, HCV viremia was HGV transmission. Of the 20 children born to HGV RNApositive mothers, 16 (80.0%) were found to be HGV RNAnot a prerequisite for HGV transmission. positive ( figure 1) . Of the 10 children with HGV viremia from whom blood samples were available during the first month of Discussion life, four were viremic at 1 month of age and during repeated testing thereafter (figure 1). Cord blood samples from two chilThe 75.0% -80.0% rate of perinatal HGV transmission that was found in our study is amazingly high, but this rate is in dren were negative, but samples from these children were positive at 10 and 26 months. Three children were negative for line with reports from other study groups [15 -17] . In our comparison, HCV transmission was rare (2.8% -4.2% of HGV at 1 month of age, but specimens from these children were positive at 18, 6, and 13 months. A cord blood sample cases); this finding is similar to those of several other studies of HCV-positive, HIV-negative mothers, most of which reported from one child was positive, but samples were negative at 13 and 27 months; further testing did not reveal antibody to HGV frequencies of õ5% to 10% [11 -14] . The prevalence of HGV viremia among healthy blood donors envelope protein E2.
None of the HGV RNA -negative children born to viremic is around 1.6% in Sweden [10] , a level correlating well with data reported from the United States [2, 4]. Since the ability mothers developed antibody to HGV envelope protein E2 during follow-up. All 16 children with HGV viremia had no cliniof HGV to induce liver disease or other manifestations at present is considered to be low, general blood donor screening for cal or biochemical signs of hepatitis.
The estimated risk for HGV transmission was 80.0% (95% HGV has not been implemented in any country. Blood donor screening is also complicated by the need for PCR assays to CI, 56.3% -97.5%) or 75.0% (15 of 20; 95% CI, 50.9% -94.0%) if the child with only positive cord blood was categodetect infectivity. Seropositivity for HGV detected with use of the recombinant envelope protein E2 as capture antigen is a rized as uninfected. This risk was significantly higher than the risk for HCV transmission: 80.0% vs. 4.2%, respectively marker of previous HGV infection; in this study, antibody to HGV envelope protein E2 was not found together with HGV (P õ .001), or 75.0% vs. 2.8%, respectively (P õ .001), if cord blood positivity was disregarded.
RNA. In some instances (probably representing active virus clearance), these two markers could however be present simulSequencing of the amplified HGV fragments from motherchild serum pairs in cases of transmission showed HGV genotaneously [20, 21] . Dual infection with HGV and HCV is common in individuals type 2a for nine serum pairs (A to I) and HGV genotype 2b for seven serum pairs (J to L) (figure 2). Isolates from serum with parenteral risk factors, like drug addicts [8, 9] . This finding was confirmed in our study, where almost 70% of the women pairs A, B, and C had identical viral sequences in the amplified region, otherwise the isolates from each serum pair showed were drug users and altogether 43 women (62.3%) had markers of present or past HGV infection. isolate-specific substitutions that were often restricted to a single nucleotide. Sequences of the isolates from serum pairs A, Despite the fact that HGV may be transmitted via parenteral routes, such as blood transfusion and intravenous drug abuse D, E, F, G, H, I, J, K, and L have been deposited at GenBank (Bethesda, MD); their accession numbers are AF063854 - [2, 4, 8, 20, 22] , our knowledge of HGV transmission still remains incomplete. Long-term carriage of HGV has been de-AF063863, respectively. Viral sequence homology was observed between isolates scribed in both children and adults [22, 23] , and perinatal transmission may be an important source of infection in blood dofrom the mother and the child in each serum pair. In serum pairs J and L, isolates from one of three children and from nors lacking parenteral risk factors. Most of our children were probably infected at birth, or one of two children, respectively, had several isolate-specific substitutions but also manifested an additional single nucleotide shortly afterward, since five of the nine viremic children analyzed early were negative for HGV RNA at birth (cord blood; substitution. This substitution remained unchanged after reamplification and during testing of alternative samples.
two) or at 1 month of age (three) and then became viremic. A further four children were HGV-positive already at 1 month, Twenty-seven (39.1%) of the 69 women were positive for antibody to HGV envelope protein E2, and HGV RNA was but earlier samples were not available from these children. Since all children, at least initially, were breast-fed, breastnot detected in any of their 33 children. A further 26 women (37.7%) were negative for all markers of present or past HGV feeding could be an alternative mode of transmission. Because of the limited number of patients and the low occurinfection, and their 28 children were also HGV RNA -negative.
Cotransmission of HGV and HCV. HGV RNA was found rence of HCV transmission, no conclusions concerning additive or synergistic effects on transmission from coinfected women in one of the three children with HCV viremia. This child was / 9c64$$ap05 03-19-99 05:22:01 cida UC: CID can be drawn. However, the only child who became convinc-15 years of follow-up, whereas 29% of the subjects remained viremic [23] . This finding makes it highly probable that longingly infected with HCV and actively produced antibody to HCV was coinfected with HGV.
term carriage also will evolve in some cases after mother-toinfant transmission. Sequencing of the HGV genomes strongly suggests that perinatal transmission did occur. The results of the single base Reassuringly for the parents, our study did not find any disease manifestations of HGV viremia in the children except difference between the isolates from the mother and one child in serum pairs J and L (both isolates in each case were the less for coinfection with the known pathogen HCV in one child. Nevertheless, to provide proper counseling, knowing that longcommon HGV genotype 2b) were repeatable by reamplification and testing of other samples. These minor changes may reflect term carriage is common and that late manifestations could still occur, further studies are of great importance. Such studies a quasispecies distribution of HGV in the mother at the time of transmission. Such a pattern may not be detectable by direct are now in progress. sequencing as done in this study. Another study from Sweden, which was restricted to sequencing of fragments from one
